Cargando…
Application of Pharmacokinetics Modelling to Predict Human Exposure of a Cationic Liposomal Subunit Antigen Vaccine System
The pharmacokinetics of a liposomal subunit antigen vaccine system composed of the cationic lipid dimethyldioctadecylammonium bromide (DDA) and the immunostimulatory agent trehalose 6,6-dibehenate (TDB) (8:1 molar ratio) combined with the Ag85B-ESAT-6 (H1) antigen were modelled using mouse in-vivo d...
Autores principales: | Badhan, Raj K. S., Khadke, Swapnil, Perrie, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750663/ https://www.ncbi.nlm.nih.gov/pubmed/29215597 http://dx.doi.org/10.3390/pharmaceutics9040057 |
Ejemplares similares
-
Point of use production of liposomal solubilised products
por: Khadke, Swapnil, et al.
Publicado: (2018) -
Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies
por: Henriksen-Lacey, Malou, et al.
Publicado: (2010) -
The Impact of Solvent Selection: Strategies to Guide the Manufacturing of Liposomes Using Microfluidics
por: Webb, Cameron, et al.
Publicado: (2019) -
Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b
por: Schmidt, Signe Tandrup, et al.
Publicado: (2020) -
The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile
por: Schmidt, Signe Tandrup, et al.
Publicado: (2016)